Molecular Characterization of Neurally Differentiated Human Bone Marrow-derived Clonal Mesenchymal Stem Cells
Tacghee YI; Hyun-Joo LEE; Yun-Kyoung CHO; Myung-Shin JEON; Sun-U SONG.
Immune Network
; : 54-65, 2014.
Artículo en Inglés | WPRIM | ID: wpr-192384
Documentos relacionados
Assessment of the LOVO device for final harvest of novel cell therapies: a Production Assistance for Cellular Therapies multi-center study.
Clinical translation of pluripotent stem cell-based therapies: successes and challenges.
Methods of the Large-Scale Production of Extracellular Vesicles.
Nonclinical and quality assessment of cell therapy products: Report on the 4th Asia Partnership Conference of Regenerative Medicine, April 15, 2021.
Understanding potential barriers and enablers to a perioperative early phase cell therapy trial.
How do I: Evaluate the safety and legitimacy of unproven cellular therapies?
Microarray fabrication techniques for multiplexed bioassay applications.
Carbon Quantum Dots as Multi-Purpose Nanomaterial in Stem Cell Therapy.
The state of cell and gene therapy in 2023.
The hope, hype and obstacles surrounding cell therapy.